Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by meticillin-resistant Staphylococcus aureus (MRSA) in the UK

David Enoch*, J. A. Karas, S. H. Aliyu

*Corresponding author for this work

    Research output: Contribution to journalShort surveypeer-review

    9 Citations (Scopus)

    Abstract

    This review outlines the oral treatment options available for treating skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus (MRSA) in the community and discusses the evidence supporting their use.

    Original languageEnglish
    Pages (from-to)497-502
    Number of pages6
    JournalInternational Journal of Antimicrobial Agents
    Volume33
    Issue number6
    DOIs
    Publication statusPublished - Jun 2009

    Keywords

    • Clindamycin
    • Fusidic acid
    • Linezolid
    • Rifampicin
    • Skin and soft-tissue infection
    • Staphylococcus aureus
    • Tetracycline
    • Trimethoprim

    Fingerprint

    Dive into the research topics of 'Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by meticillin-resistant Staphylococcus aureus (MRSA) in the UK'. Together they form a unique fingerprint.

    Cite this